In prostate cancer, Shulby and colleagues demonstrated in vitro that CX3CL1 and its receptor direct prostate cancer cells to the bone marrow and guide their preferential migration towards human osteoblasts. Here, CX3CL1 is linked to Familial prostate cancer.